JP2023544633A5 - - Google Patents

Info

Publication number
JP2023544633A5
JP2023544633A5 JP2023521740A JP2023521740A JP2023544633A5 JP 2023544633 A5 JP2023544633 A5 JP 2023544633A5 JP 2023521740 A JP2023521740 A JP 2023521740A JP 2023521740 A JP2023521740 A JP 2023521740A JP 2023544633 A5 JP2023544633 A5 JP 2023544633A5
Authority
JP
Japan
Prior art keywords
homologous
region
nucleotide sequence
cells
rag1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023521740A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544633A (ja
Filing date
Publication date
Priority claimed from GBGB2016139.4A external-priority patent/GB202016139D0/en
Priority claimed from AU2021202657A external-priority patent/AU2021202657A1/en
Application filed filed Critical
Priority claimed from PCT/EP2021/078222 external-priority patent/WO2022079054A1/en
Publication of JP2023544633A publication Critical patent/JP2023544633A/ja
Publication of JP2023544633A5 publication Critical patent/JP2023544633A5/ja
Pending legal-status Critical Current

Links

JP2023521740A 2020-10-12 2021-10-12 治療における使用のためのrag1の置き換え Pending JP2023544633A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB2016139.4A GB202016139D0 (en) 2020-10-12 2020-10-12 Polynucleotide
GB2016139.4 2020-10-12
AU2021202657A AU2021202657A1 (en) 2021-04-28 2021-04-28 Polynucleotide
AU2021202657 2021-04-28
PCT/EP2021/078222 WO2022079054A1 (en) 2020-10-12 2021-10-12 Replacement of rag1 for use in therapy

Publications (2)

Publication Number Publication Date
JP2023544633A JP2023544633A (ja) 2023-10-24
JP2023544633A5 true JP2023544633A5 (https=) 2024-10-22

Family

ID=78413971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023521740A Pending JP2023544633A (ja) 2020-10-12 2021-10-12 治療における使用のためのrag1の置き換え

Country Status (6)

Country Link
US (1) US20230365996A1 (https=)
EP (1) EP4225900A1 (https=)
JP (1) JP2023544633A (https=)
AU (1) AU2021359781A1 (https=)
IL (1) IL302031A (https=)
WO (1) WO2022079054A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024538769A (ja) * 2021-10-12 2024-10-23 オスペダーレ サン ラファエレ エス.アール.エル Rag1遺伝子における突然変異を修正するのに有用なポリヌクレオチド
GB202206346D0 (en) * 2022-04-29 2022-06-15 Ospedale San Raffaele Srl Gene therapy
WO2025073293A1 (en) * 2023-10-02 2025-04-10 Consorcio Centro De Investigación Biomédica En Red Gene editing methods for cd34+ cells to achieve clinically relevant efficacies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT904392E (pt) 1996-10-17 2001-06-29 Oxford Biomedica Ltd Vectores retrovirais
US20190038771A1 (en) * 2016-02-02 2019-02-07 Crispr Therapeutics Ag Materials and methods for treatment of severe combined immunodeficiency (scid) or omenn syndrome
AU2019294294A1 (en) 2018-06-25 2021-02-11 Fondazione Telethon Ets Gene therapy

Similar Documents

Publication Publication Date Title
JP2023544633A5 (https=)
JP7651190B2 (ja) 遺伝子操作rnaを用いた内因性adarによる標的化rna編集
US12065669B2 (en) Methods and compositions for modulating a genome
US20230242899A1 (en) Methods and compositions for modulating a genome
Toyonaga et al. Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain.
US20220127621A1 (en) Fusion proteins and fusion ribonucleic acids for tracking and manipulating cellular rna
JP2024534523A5 (https=)
CN109843930B (zh) 酸性α-葡萄糖苷酶变体及其用途
JP2022500066A5 (https=)
JP2022505402A5 (https=)
JP2021520202A5 (https=)
JP2023070682A5 (https=)
CN118416088A (zh) 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向
JP2020518268A5 (https=)
JP2006502748A5 (https=)
JP2022553573A5 (https=)
EP4277990A1 (en) Targeted rna editing by leveraging endogenous adar using engineered rnas
Renbaum et al. Isolation and characterization of the full-length 3′ untranslated region of the human von Hippel-Lindau tumor suppressor gene
US20250312376A1 (en) Compositions and methods for modulating a genome in t cells, induced pluripotent stem cells, and respiratory epithelial cells
JP2023504826A5 (https=)
JP2024534991A5 (https=)
JP2024503091A5 (https=)
JP2023544702A5 (https=)
CN116194578A (zh) 通过靶向dux4基因来治疗面肩肱型肌营养不良症(fshd)的方法
WO2024083095A1 (zh) 环状rna及载体和载体的应用